NMS·Healthcare·$687M·#145 / 520 in Healthcare
BVS Bioventus Inc.
59SPECULATIVE
CATEGORY BREAKDOWN
GROWTH0
QUALITY72
STABILITY67
VALUATION99
GOVERNANCE74
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-0.9%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
68.3%
97
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
159.7%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.2x
99
< 3x strong
Rule of 40
Growth rate plus operating margin
9
34
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
11.3%
68
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+2.1%
87
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE BVS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when BVS's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.